Yavuz Nuri Ertaş
Yavuz Nuri Ertaş publishes mostly in Biomedical Engineering, Molecular Biology and Biomaterials, on topics such as Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery and Advanced biosensing and bioanalysis techniques.
- World rank
- #50,837 of 7,710,434 ranked researchers
- Rank in Türkiye
- #128 of 117,622
- Works
- 135
- Citations
- 4.8k
- Citations per work
- 35.6
What does Yavuz Nuri Ertaş research?
Yavuz Nuri Ertaş's work is mostly in Materials Science (25%), Engineering (18%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences5843.2%
- Materials Science3425.3%
- Engineering2417.9%
- Everything else5439.7%
- Life Sciences2317.1%
- 1Biomedical Engineering18% of their works
- 2Molecular Biology14% of their works
- 3Biomaterials13% of their works
- 4Materials Chemistry9% of their works
- 5Cancer Research3% of their works
- 6Electronic, Optical and Magnetic Materials3% of their works
Research topics
- Nanoplatforms for cancer theranostics
- Nanoparticle-Based Drug Delivery
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- 3D Printing in Biomedical Research
- Electrospun Nanofibers in Biomedical Applications
- Cancer-related molecular mechanisms research
- Advanced NMR Techniques and Applications
Which keywords describe Yavuz Nuri Ertaş's research?
The keywords of their largest research topics: Nanoparticles, Tumor Targeting, Biomedical Applications, Drug Delivery, Photothermal Therapy, Reactive Oxygen Species, Cancer Therapy and Nanocarriers.
- Solid-State NMR
- Long Noncoding RNAs
- Nanofibers
- Electrospinning
- siRNA Delivery
- Self-Assembly
- Tissue Engineering
- Nanocarriers
- Reactive Oxygen Species
- Drug Delivery
- Tumor Targeting
- Nanoparticles
- Biomedical Applications
- Photothermal Therapy
- Cancer Therapy
- Regenerative Medicine
- DNA nanotechnology
- RNA Interference
- Bioprinting
- Microfluidic Devices
- Cancer
- NMR Spectroscopy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Nanoparticles773 topics
- Tumor Targeting642 topics
- Biomedical Applications392 topics
- Drug Delivery392 topics
- Photothermal Therapy341 topic
- Reactive Oxygen Species341 topic
- Cancer Therapy301 topic
- Nanocarriers301 topic
- Regenerative Medicine182 topics
- Tissue Engineering182 topics
- DNA nanotechnology131 topic
- Self-Assembly131 topic
- RNA Interference101 topic
- siRNA Delivery101 topic
- Bioprinting91 topic
- Electrospinning91 topic
- Microfluidic Devices91 topic
- Nanofibers91 topic
- Cancer81 topic
- Long Noncoding RNAs81 topic
- NMR Spectroscopy71 topic
- Solid-State NMR71 topic
Where does Yavuz Nuri Ertaş work?
Yavuz Nuri Ertaş's main affiliation in the publication record is Erciyes University, Türkiye.
How many publications and citations does Yavuz Nuri Ertaş have?
OpenAlex counts 135 works and 4,812 citations for Yavuz Nuri Ertaş, an h-index of 41, ranking #50,837 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yavuz Nuri Ertaş. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.